IndraLab

Statements

Spironolactone inhibits KCNH2. 1 / 1

| 1

reach

"Both spironolactone (SP) and its main metabolite, canrenoic acid (CA), prolong cardiac action potential duration and decrease the Kv11.1 (HERG) current."

15980874

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Spironolactone inhibits KCNH2. 1 / 1

INDRA sources:

Databases

Reading